NCT00625248

Prospective Evaluation of Bleeding Risk of Anticoagulant and Anti-platelet Therapy

A Prospective Evaluation of Bleeding Risk of Anticoagulant and Antiplatelet Therapy for Interventional Techniques

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 12,000 (actual)
• Sponsor: Pain Management Center of Paducah · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study will evaluate bleeding risk and differences in outcomes in patients receiving and not receiving anticoagulant or antiplatelet therapy

Detailed description

1. To evaluate bleeding risk in interventional procedures in patients with or without antiplatelet and/or anticoagulant therapy. 2. To evaluate differences in outcomes in patients not receiving any anticoagulant or antiplatelet therapy compared to patients receiving various types of drugs with anticoagulant or antiplatelet therapeutic effects. 3. To evaluate and compare the adverse event profiling all patients.

Conditions

• Bleeding

Interventions

Type	Name	Description
DRUG	Antithrombotics	With or without or discontinuted use of Antithrombotics

Timeline

• Start date: 2008-02-01
• Primary completion: 2009-01-01
• Completion: 2010-01-01
• First posted: 2008-02-28
• Last updated: 2013-06-24

Locations

1 site across 1 country: United States